You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

farletuzumab

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum-Sensitive Ovarian Cancer in First Relapse Trial in Worldwide (Farletuzumab, Placebo)

Completed
Has Results
  • Platinum-Sensitive Ovarian Cancer in First Relapse
  • Farletuzumab
  • Placebo
  • Phoenix, Arizona
  • +67 more
Aug 9, 2021

Adenocarcinoma of the Lung Trial in Worldwide (biological, other, drug)

Completed
Has Results
  • Adenocarcinoma of the Lung
  • Farletuzumab
  • +5 more
  • Chandler, Arizona
  • +92 more
Aug 10, 2020

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Germany, United States (Farletuzumab, Chemo Plus Far)

Completed
Has Results
  • Ovarian Cancer
  • +2 more
  • Farletuzumab
  • Chemo Plus Far
  • San Diego, California
  • +19 more
Sep 4, 2015

Resectable, Non-functioning Pituitary Adenoma Trial in Atlanta (Farletuzumab)

Withdrawn
  • Resectable, Non-functioning Pituitary Adenoma
  • Farletuzumab
  • Atlanta, Georgia
    Emory University
Nov 1, 2013